Upgrade to SI Premium - Free Trial

Mylan (MYL) Announces Launch of Avonza in India

August 8, 2017 5:56 AM
Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N.V. (NASDAQ: MYL) has received marketing authorization from the Drug Controller General ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Hot FDA News Management Comments

Next Articles